img

Global IVIG Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global IVIG Market Insights, Forecast to 2034

Global IVIG market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, IVIG industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, IVIG key manufacturers include Green Cross, BSV, Hualan Bio, RAAS, YUAN DA SHUYANG, Kangbao Bio, Tiantan Bio, Taibang Bio and Weiguang Bio, etc. Green Cross, BSV, Hualan Bio are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of IVIG were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole IVIG market and estimated to attract more attentions from industry insiders and investors.
IVIG can be divided into Injection IVIG and Lyophilized Powder IVIG, etc. Injection IVIG is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
IVIG is widely used in various fields, such as Multiple Sclerosis(MS), Myasthenia Gravis(MG), Multifocal Motor Neuropathy(MMN) and Multifocal Acquired Sensory and Motor Neuropathy(MADSAM), etc. Multiple Sclerosis(MS) provides greatest supports to the IVIG industry development. In 2022, global % sales of IVIG went into Multiple Sclerosis(MS) filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global IVIG market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global IVIG market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Green Cross
BSV
Hualan Bio
RAAS
YUAN DA SHUYANG
Kangbao Bio
Tiantan Bio
Taibang Bio
Weiguang Bio
SIBP
TONROL
RUIDE Bio
BOYA Bio
RUIDE Bio
Xinxing Medicine
Weilun Bio
WIBP
Segment by Type
Injection IVIG
Lyophilized Powder IVIG

Segment by Application


Multiple Sclerosis(MS)
Myasthenia Gravis(MG)
Multifocal Motor Neuropathy(MMN)
Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Dermatomyositis
Polymyositis

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ IVIG plant distribution, commercial date of IVIG, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, IVIG introduction, etc. IVIG Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of IVIG
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 IVIG Product Introduction
1.2 Market by Type
1.2.1 Global IVIG Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Injection IVIG
1.2.3 Lyophilized Powder IVIG
1.3 Market by Application
1.3.1 Global IVIG Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Multiple Sclerosis(MS)
1.3.3 Myasthenia Gravis(MG)
1.3.4 Multifocal Motor Neuropathy(MMN)
1.3.5 Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
1.3.6 Dermatomyositis
1.3.7 Polymyositis
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global IVIG Sales Estimates and Forecasts 2018-2029
2.2 Global IVIG Revenue by Region
2.2.1 Global IVIG Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global IVIG Revenue by Region (2018-2024)
2.2.3 Global IVIG Revenue by Region (2024-2029)
2.2.4 Global IVIG Revenue Market Share by Region (2018-2029)
2.3 Global IVIG Sales Estimates and Forecasts 2018-2029
2.4 Global IVIG Sales by Region
2.4.1 Global IVIG Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global IVIG Sales by Region (2018-2024)
2.4.3 Global IVIG Sales by Region (2024-2029)
2.4.4 Global IVIG Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global IVIG Sales by Manufacturers
3.1.1 Global IVIG Sales by Manufacturers (2018-2024)
3.1.2 Global IVIG Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of IVIG in 2022
3.2 Global IVIG Revenue by Manufacturers
3.2.1 Global IVIG Revenue by Manufacturers (2018-2024)
3.2.2 Global IVIG Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by IVIG Revenue in 2022
3.3 Global Key Players of IVIG, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global IVIG Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global IVIG Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of IVIG, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of IVIG, Product Offered and Application
3.8 Global Key Manufacturers of IVIG, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global IVIG Sales by Type
4.1.1 Global IVIG Historical Sales by Type (2018-2024)
4.1.2 Global IVIG Forecasted Sales by Type (2024-2029)
4.1.3 Global IVIG Sales Market Share by Type (2018-2029)
4.2 Global IVIG Revenue by Type
4.2.1 Global IVIG Historical Revenue by Type (2018-2024)
4.2.2 Global IVIG Forecasted Revenue by Type (2024-2029)
4.2.3 Global IVIG Revenue Market Share by Type (2018-2029)
4.3 Global IVIG Price by Type
4.3.1 Global IVIG Price by Type (2018-2024)
4.3.2 Global IVIG Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global IVIG Sales by Application
5.1.1 Global IVIG Historical Sales by Application (2018-2024)
5.1.2 Global IVIG Forecasted Sales by Application (2024-2029)
5.1.3 Global IVIG Sales Market Share by Application (2018-2029)
5.2 Global IVIG Revenue by Application
5.2.1 Global IVIG Historical Revenue by Application (2018-2024)
5.2.2 Global IVIG Forecasted Revenue by Application (2024-2029)
5.2.3 Global IVIG Revenue Market Share by Application (2018-2029)
5.3 Global IVIG Price by Application
5.3.1 Global IVIG Price by Application (2018-2024)
5.3.2 Global IVIG Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada IVIG Market Size by Type
6.1.1 US & Canada IVIG Sales by Type (2018-2029)
6.1.2 US & Canada IVIG Revenue by Type (2018-2029)
6.2 US & Canada IVIG Market Size by Application
6.2.1 US & Canada IVIG Sales by Application (2018-2029)
6.2.2 US & Canada IVIG Revenue by Application (2018-2029)
6.3 US & Canada IVIG Market Size by Country
6.3.1 US & Canada IVIG Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada IVIG Sales by Country (2018-2029)
6.3.3 US & Canada IVIG Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe IVIG Market Size by Type
7.1.1 Europe IVIG Sales by Type (2018-2029)
7.1.2 Europe IVIG Revenue by Type (2018-2029)
7.2 Europe IVIG Market Size by Application
7.2.1 Europe IVIG Sales by Application (2018-2029)
7.2.2 Europe IVIG Revenue by Application (2018-2029)
7.3 Europe IVIG Market Size by Country
7.3.1 Europe IVIG Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe IVIG Sales by Country (2018-2029)
7.3.3 Europe IVIG Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China IVIG Market Size
8.1.1 China IVIG Sales (2018-2029)
8.1.2 China IVIG Revenue (2018-2029)
8.2 China IVIG Market Size by Application
8.2.1 China IVIG Sales by Application (2018-2029)
8.2.2 China IVIG Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia IVIG Market Size by Type
9.1.1 Asia IVIG Sales by Type (2018-2029)
9.1.2 Asia IVIG Revenue by Type (2018-2029)
9.2 Asia IVIG Market Size by Application
9.2.1 Asia IVIG Sales by Application (2018-2029)
9.2.2 Asia IVIG Revenue by Application (2018-2029)
9.3 Asia IVIG Sales by Region
9.3.1 Asia IVIG Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia IVIG Revenue by Region (2018-2029)
9.3.3 Asia IVIG Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America IVIG Market Size by Type
10.1.1 Middle East, Africa and Latin America IVIG Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America IVIG Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America IVIG Market Size by Application
10.2.1 Middle East, Africa and Latin America IVIG Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America IVIG Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America IVIG Sales by Country
10.3.1 Middle East, Africa and Latin America IVIG Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America IVIG Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America IVIG Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Green Cross
11.1.1 Green Cross Company Information
11.1.2 Green Cross Overview
11.1.3 Green Cross IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Green Cross IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Green Cross Recent Developments
11.2 BSV
11.2.1 BSV Company Information
11.2.2 BSV Overview
11.2.3 BSV IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 BSV IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 BSV Recent Developments
11.3 Hualan Bio
11.3.1 Hualan Bio Company Information
11.3.2 Hualan Bio Overview
11.3.3 Hualan Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Hualan Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Hualan Bio Recent Developments
11.4 RAAS
11.4.1 RAAS Company Information
11.4.2 RAAS Overview
11.4.3 RAAS IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 RAAS IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 RAAS Recent Developments
11.5 YUAN DA SHUYANG
11.5.1 YUAN DA SHUYANG Company Information
11.5.2 YUAN DA SHUYANG Overview
11.5.3 YUAN DA SHUYANG IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 YUAN DA SHUYANG IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 YUAN DA SHUYANG Recent Developments
11.6 Kangbao Bio
11.6.1 Kangbao Bio Company Information
11.6.2 Kangbao Bio Overview
11.6.3 Kangbao Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Kangbao Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Kangbao Bio Recent Developments
11.7 Tiantan Bio
11.7.1 Tiantan Bio Company Information
11.7.2 Tiantan Bio Overview
11.7.3 Tiantan Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Tiantan Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tiantan Bio Recent Developments
11.8 Taibang Bio
11.8.1 Taibang Bio Company Information
11.8.2 Taibang Bio Overview
11.8.3 Taibang Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Taibang Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Taibang Bio Recent Developments
11.9 Weiguang Bio
11.9.1 Weiguang Bio Company Information
11.9.2 Weiguang Bio Overview
11.9.3 Weiguang Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Weiguang Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Weiguang Bio Recent Developments
11.10 SIBP
11.10.1 SIBP Company Information
11.10.2 SIBP Overview
11.10.3 SIBP IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 SIBP IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 SIBP Recent Developments
11.11 TONROL
11.11.1 TONROL Company Information
11.11.2 TONROL Overview
11.11.3 TONROL IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 TONROL IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 TONROL Recent Developments
11.12 RUIDE Bio
11.12.1 RUIDE Bio Company Information
11.12.2 RUIDE Bio Overview
11.12.3 RUIDE Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 RUIDE Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 RUIDE Bio Recent Developments
11.13 BOYA Bio
11.13.1 BOYA Bio Company Information
11.13.2 BOYA Bio Overview
11.13.3 BOYA Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 BOYA Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 BOYA Bio Recent Developments
11.14 RUIDE Bio
11.14.1 RUIDE Bio Company Information
11.14.2 RUIDE Bio Overview
11.14.3 RUIDE Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 RUIDE Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 RUIDE Bio Recent Developments
11.15 Xinxing Medicine
11.15.1 Xinxing Medicine Company Information
11.15.2 Xinxing Medicine Overview
11.15.3 Xinxing Medicine IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Xinxing Medicine IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Xinxing Medicine Recent Developments
11.16 Weilun Bio
11.16.1 Weilun Bio Company Information
11.16.2 Weilun Bio Overview
11.16.3 Weilun Bio IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 Weilun Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Weilun Bio Recent Developments
11.17 WIBP
11.17.1 WIBP Company Information
11.17.2 WIBP Overview
11.17.3 WIBP IVIG Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 WIBP IVIG Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 WIBP Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 IVIG Industry Chain Analysis
12.2 IVIG Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 IVIG Production Mode & Process
12.4 IVIG Sales and Marketing
12.4.1 IVIG Sales Channels
12.4.2 IVIG Distributors
12.5 IVIG Customers
13 Market Dynamics
13.1 IVIG Industry Trends
13.2 IVIG Market Drivers
13.3 IVIG Market Challenges
13.4 IVIG Market Restraints
14 Key Findings in The Global IVIG Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global IVIG Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Injection IVIG
Table 3. Major Manufacturers of Lyophilized Powder IVIG
Table 4. Global IVIG Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global IVIG Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global IVIG Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global IVIG Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global IVIG Revenue Market Share by Region (2018-2024)
Table 9. Global IVIG Revenue Market Share by Region (2024-2029)
Table 10. Global IVIG Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global IVIG Sales by Region (2018-2024) & (K Pcs)
Table 12. Global IVIG Sales by Region (2024-2029) & (K Pcs)
Table 13. Global IVIG Sales Market Share by Region (2018-2024)
Table 14. Global IVIG Sales Market Share by Region (2024-2029)
Table 15. Global IVIG Sales by Manufacturers (2018-2024) & (K Pcs)
Table 16. Global IVIG Sales Share by Manufacturers (2018-2024)
Table 17. Global IVIG Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global IVIG Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of IVIG, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. IVIG Price by Manufacturers 2018-2024 (USD/Pcs)
Table 21. Global IVIG Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global IVIG by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVIG as of 2022)
Table 23. Global Key Manufacturers of IVIG, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of IVIG, Product Offered and Application
Table 25. Global Key Manufacturers of IVIG, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global IVIG Sales by Type (2018-2024) & (K Pcs)
Table 28. Global IVIG Sales by Type (2024-2029) & (K Pcs)
Table 29. Global IVIG Sales Share by Type (2018-2024)
Table 30. Global IVIG Sales Share by Type (2024-2029)
Table 31. Global IVIG Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global IVIG Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global IVIG Revenue Share by Type (2018-2024)
Table 34. Global IVIG Revenue Share by Type (2024-2029)
Table 35. IVIG Price by Type (2018-2024) & (USD/Pcs)
Table 36. Global IVIG Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 37. Global IVIG Sales by Application (2018-2024) & (K Pcs)
Table 38. Global IVIG Sales by Application (2024-2029) & (K Pcs)
Table 39. Global IVIG Sales Share by Application (2018-2024)
Table 40. Global IVIG Sales Share by Application (2024-2029)
Table 41. Global IVIG Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global IVIG Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global IVIG Revenue Share by Application (2018-2024)
Table 44. Global IVIG Revenue Share by Application (2024-2029)
Table 45. IVIG Price by Application (2018-2024) & (USD/Pcs)
Table 46. Global IVIG Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 47. US & Canada IVIG Sales by Type (2018-2024) & (K Pcs)
Table 48. US & Canada IVIG Sales by Type (2024-2029) & (K Pcs)
Table 49. US & Canada IVIG Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada IVIG Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada IVIG Sales by Application (2018-2024) & (K Pcs)
Table 52. US & Canada IVIG Sales by Application (2024-2029) & (K Pcs)
Table 53. US & Canada IVIG Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada IVIG Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada IVIG Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada IVIG Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada IVIG Sales by Country (2018-2024) & (K Pcs)
Table 59. US & Canada IVIG Sales by Country (2024-2029) & (K Pcs)
Table 60. Europe IVIG Sales by Type (2018-2024) & (K Pcs)
Table 61. Europe IVIG Sales by Type (2024-2029) & (K Pcs)
Table 62. Europe IVIG Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe IVIG Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe IVIG Sales by Application (2018-2024) & (K Pcs)
Table 65. Europe IVIG Sales by Application (2024-2029) & (K Pcs)
Table 66. Europe IVIG Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe IVIG Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe IVIG Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe IVIG Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe IVIG Sales by Country (2018-2024) & (K Pcs)
Table 72. Europe IVIG Sales by Country (2024-2029) & (K Pcs)
Table 73. China IVIG Sales by Type (2018-2024) & (K Pcs)
Table 74. China IVIG Sales by Type (2024-2029) & (K Pcs)
Table 75. China IVIG Revenue by Type (2018-2024) & (US$ Million)
Table 76. China IVIG Revenue by Type (2024-2029) & (US$ Million)
Table 77. China IVIG Sales by Application (2018-2024) & (K Pcs)
Table 78. China IVIG Sales by Application (2024-2029) & (K Pcs)
Table 79. China IVIG Revenue by Application (2018-2024) & (US$ Million)
Table 80. China IVIG Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia IVIG Sales by Type (2018-2024) & (K Pcs)
Table 82. Asia IVIG Sales by Type (2024-2029) & (K Pcs)
Table 83. Asia IVIG Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia IVIG Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia IVIG Sales by Application (2018-2024) & (K Pcs)
Table 86. Asia IVIG Sales by Application (2024-2029) & (K Pcs)
Table 87. Asia IVIG Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia IVIG Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia IVIG Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia IVIG Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia IVIG Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia IVIG Sales by Region (2018-2024) & (K Pcs)
Table 93. Asia IVIG Sales by Region (2024-2029) & (K Pcs)
Table 94. Middle East, Africa and Latin America IVIG Sales by Type (2018-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America IVIG Sales by Type (2024-2029) & (K Pcs)
Table 96. Middle East, Africa and Latin America IVIG Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America IVIG Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America IVIG Sales by Application (2018-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America IVIG Sales by Application (2024-2029) & (K Pcs)
Table 100. Middle East, Africa and Latin America IVIG Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America IVIG Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America IVIG Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America IVIG Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America IVIG Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America IVIG Sales by Country (2018-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America IVIG Sales by Country (2024-2029) & (K Pcs)
Table 107. Green Cross Company Information
Table 108. Green Cross Description and Major Businesses
Table 109. Green Cross IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Green Cross IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Green Cross Recent Developments
Table 112. BSV Company Information
Table 113. BSV Description and Major Businesses
Table 114. BSV IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. BSV IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. BSV Recent Developments
Table 117. Hualan Bio Company Information
Table 118. Hualan Bio Description and Major Businesses
Table 119. Hualan Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Hualan Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Hualan Bio Recent Developments
Table 122. RAAS Company Information
Table 123. RAAS Description and Major Businesses
Table 124. RAAS IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. RAAS IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. RAAS Recent Developments
Table 127. YUAN DA SHUYANG Company Information
Table 128. YUAN DA SHUYANG Description and Major Businesses
Table 129. YUAN DA SHUYANG IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. YUAN DA SHUYANG IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. YUAN DA SHUYANG Recent Developments
Table 132. Kangbao Bio Company Information
Table 133. Kangbao Bio Description and Major Businesses
Table 134. Kangbao Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. Kangbao Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Kangbao Bio Recent Developments
Table 137. Tiantan Bio Company Information
Table 138. Tiantan Bio Description and Major Businesses
Table 139. Tiantan Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Tiantan Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Tiantan Bio Recent Developments
Table 142. Taibang Bio Company Information
Table 143. Taibang Bio Description and Major Businesses
Table 144. Taibang Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Taibang Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Taibang Bio Recent Developments
Table 147. Weiguang Bio Company Information
Table 148. Weiguang Bio Description and Major Businesses
Table 149. Weiguang Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. Weiguang Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Weiguang Bio Recent Developments
Table 152. SIBP Company Information
Table 153. SIBP Description and Major Businesses
Table 154. SIBP IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. SIBP IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. SIBP Recent Developments
Table 157. TONROL Company Information
Table 158. TONROL Description and Major Businesses
Table 159. TONROL IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. TONROL IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. TONROL Recent Developments
Table 162. RUIDE Bio Company Information
Table 163. RUIDE Bio Description and Major Businesses
Table 164. RUIDE Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. RUIDE Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. RUIDE Bio Recent Developments
Table 167. BOYA Bio Company Information
Table 168. BOYA Bio Description and Major Businesses
Table 169. BOYA Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. BOYA Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. BOYA Bio Recent Developments
Table 172. RUIDE Bio Company Information
Table 173. RUIDE Bio Description and Major Businesses
Table 174. RUIDE Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 175. RUIDE Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. RUIDE Bio Recent Developments
Table 177. Xinxing Medicine Company Information
Table 178. Xinxing Medicine Description and Major Businesses
Table 179. Xinxing Medicine IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Xinxing Medicine IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Xinxing Medicine Recent Developments
Table 182. Weilun Bio Company Information
Table 183. Weilun Bio Description and Major Businesses
Table 184. Weilun Bio IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 185. Weilun Bio IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. Weilun Bio Recent Developments
Table 187. WIBP Company Information
Table 188. WIBP Description and Major Businesses
Table 189. WIBP IVIG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 190. WIBP IVIG Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. WIBP Recent Developments
Table 192. Key Raw Materials Lists
Table 193. Raw Materials Key Suppliers Lists
Table 194. IVIG Distributors List
Table 195. IVIG Customers List
Table 196. IVIG Market Trends
Table 197. IVIG Market Drivers
Table 198. IVIG Market Challenges
Table 199. IVIG Market Restraints
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. IVIG Product Picture
Figure 2. Global IVIG Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global IVIG Market Share by Type in 2022 & 2029
Figure 4. Injection IVIG Product Picture
Figure 5. Lyophilized Powder IVIG Product Picture
Figure 6. Global IVIG Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global IVIG Market Share by Application in 2022 & 2029
Figure 8. Multiple Sclerosis(MS)
Figure 9. Myasthenia Gravis(MG)
Figure 10. Multifocal Motor Neuropathy(MMN)
Figure 11. Multifocal Acquired Sensory and Motor Neuropathy(MADSAM)
Figure 12. Dermatomyositis
Figure 13. Polymyositis
Figure 14. IVIG Report Years Considered
Figure 15. Global IVIG Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global IVIG Revenue 2018-2029 (US$ Million)
Figure 17. Global IVIG Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global IVIG Revenue Market Share by Region (2018-2029)
Figure 19. Global IVIG Sales 2018-2029 ((K Pcs)
Figure 20. Global IVIG Sales Market Share by Region (2018-2029)
Figure 21. US & Canada IVIG Sales YoY (2018-2029) & (K Pcs)
Figure 22. US & Canada IVIG Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe IVIG Sales YoY (2018-2029) & (K Pcs)
Figure 24. Europe IVIG Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China IVIG Sales YoY (2018-2029) & (K Pcs)
Figure 26. China IVIG Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) IVIG Sales YoY (2018-2029) & (K Pcs)
Figure 28. Asia (excluding China) IVIG Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America IVIG Sales YoY (2018-2029) & (K Pcs)
Figure 30. Middle East, Africa and Latin America IVIG Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The IVIG Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of IVIG in the World: Market Share by IVIG Revenue in 2022
Figure 33. Global IVIG Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global IVIG Sales Market Share by Type (2018-2029)
Figure 35. Global IVIG Revenue Market Share by Type (2018-2029)
Figure 36. Global IVIG Sales Market Share by Application (2018-2029)
Figure 37. Global IVIG Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada IVIG Sales Market Share by Type (2018-2029)
Figure 39. US & Canada IVIG Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada IVIG Sales Market Share by Application (2018-2029)
Figure 41. US & Canada IVIG Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada IVIG Revenue Share by Country (2018-2029)
Figure 43. US & Canada IVIG Sales Share by Country (2018-2029)
Figure 44. U.S. IVIG Revenue (2018-2029) & (US$ Million)
Figure 45. Canada IVIG Revenue (2018-2029) & (US$ Million)
Figure 46. Europe IVIG Sales Market Share by Type (2018-2029)
Figure 47. Europe IVIG Revenue Market Share by Type (2018-2029)
Figure 48. Europe IVIG Sales Market Share by Application (2018-2029)
Figure 49. Europe IVIG Revenue Market Share by Application (2018-2029)
Figure 50. Europe IVIG Revenue Share by Country (2018-2029)
Figure 51. Europe IVIG Sales Share by Country (2018-2029)
Figure 52. Germany IVIG Revenue (2018-2029) & (US$ Million)
Figure 53. France IVIG Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. IVIG Revenue (2018-2029) & (US$ Million)
Figure 55. Italy IVIG Revenue (2018-2029) & (US$ Million)
Figure 56. Russia IVIG Revenue (2018-2029) & (US$ Million)
Figure 57. China IVIG Sales Market Share by Type (2018-2029)
Figure 58. China IVIG Revenue Market Share by Type (2018-2029)
Figure 59. China IVIG Sales Market Share by Application (2018-2029)
Figure 60. China IVIG Revenue Market Share by Application (2018-2029)
Figure 61. Asia IVIG Sales Market Share by Type (2018-2029)
Figure 62. Asia IVIG Revenue Market Share by Type (2018-2029)
Figure 63. Asia IVIG Sales Market Share by Application (2018-2029)
Figure 64. Asia IVIG Revenue Market Share by Application (2018-2029)
Figure 65. Asia IVIG Revenue Share by Region (2018-2029)
Figure 66. Asia IVIG Sales Share by Region (2018-2029)
Figure 67. Japan IVIG Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea IVIG Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan IVIG Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia IVIG Revenue (2018-2029) & (US$ Million)
Figure 71. India IVIG Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America IVIG Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America IVIG Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America IVIG Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America IVIG Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America IVIG Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America IVIG Sales Share by Country (2018-2029)
Figure 78. Brazil IVIG Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico IVIG Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey IVIG Revenue (2018-2029) & (US$ Million)
Figure 81. Israel IVIG Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries IVIG Revenue (2018-2029) & (US$ Million)
Figure 83. IVIG Value Chain
Figure 84. IVIG Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed